Cargando…
S234: UPDATED CLINICAL RESULTS OF FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FAST CAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428513/ http://dx.doi.org/10.1097/01.HS9.0000967848.32931.92 |
| _version_ | 1785090488214224896 |
|---|---|
| author | Chen, Xinfeng Ping, Yu LI, Ling Zhang, Lei Zhang, Xudong Huang, Jianmin Liu, Jia LI, Gui He, Jiaping Zhang, Hua Zhao, Wei Weng, Lihong Yin, Wenjie Shen, Lianjun Cao, Wei William LI, Wenling Zhang, Mingzhi Zhang, Yi |
| author_facet | Chen, Xinfeng Ping, Yu LI, Ling Zhang, Lei Zhang, Xudong Huang, Jianmin Liu, Jia LI, Gui He, Jiaping Zhang, Hua Zhao, Wei Weng, Lihong Yin, Wenjie Shen, Lianjun Cao, Wei William LI, Wenling Zhang, Mingzhi Zhang, Yi |
| author_sort | Chen, Xinfeng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428513 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104285132023-08-17 S234: UPDATED CLINICAL RESULTS OF FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FAST CAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA Chen, Xinfeng Ping, Yu LI, Ling Zhang, Lei Zhang, Xudong Huang, Jianmin Liu, Jia LI, Gui He, Jiaping Zhang, Hua Zhao, Wei Weng, Lihong Yin, Wenjie Shen, Lianjun Cao, Wei William LI, Wenling Zhang, Mingzhi Zhang, Yi Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428513/ http://dx.doi.org/10.1097/01.HS9.0000967848.32931.92 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Chen, Xinfeng Ping, Yu LI, Ling Zhang, Lei Zhang, Xudong Huang, Jianmin Liu, Jia LI, Gui He, Jiaping Zhang, Hua Zhao, Wei Weng, Lihong Yin, Wenjie Shen, Lianjun Cao, Wei William LI, Wenling Zhang, Mingzhi Zhang, Yi S234: UPDATED CLINICAL RESULTS OF FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FAST CAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA |
| title | S234: UPDATED CLINICAL RESULTS OF FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FAST CAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA |
| title_full | S234: UPDATED CLINICAL RESULTS OF FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FAST CAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA |
| title_fullStr | S234: UPDATED CLINICAL RESULTS OF FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FAST CAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA |
| title_full_unstemmed | S234: UPDATED CLINICAL RESULTS OF FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FAST CAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA |
| title_short | S234: UPDATED CLINICAL RESULTS OF FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FAST CAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA |
| title_sort | s234: updated clinical results of first-in-human study of cd19/bcma dual-targeting fast car-t gc012f for patients with relapsed/refractory b-cell non-hodgkin’s lymphoma |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428513/ http://dx.doi.org/10.1097/01.HS9.0000967848.32931.92 |
| work_keys_str_mv | AT chenxinfeng s234updatedclinicalresultsoffirstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT pingyu s234updatedclinicalresultsoffirstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT liling s234updatedclinicalresultsoffirstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT zhanglei s234updatedclinicalresultsoffirstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT zhangxudong s234updatedclinicalresultsoffirstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT huangjianmin s234updatedclinicalresultsoffirstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT liujia s234updatedclinicalresultsoffirstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT ligui s234updatedclinicalresultsoffirstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT hejiaping s234updatedclinicalresultsoffirstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT zhanghua s234updatedclinicalresultsoffirstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT zhaowei s234updatedclinicalresultsoffirstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT wenglihong s234updatedclinicalresultsoffirstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT yinwenjie s234updatedclinicalresultsoffirstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT shenlianjun s234updatedclinicalresultsoffirstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT caoweiwilliam s234updatedclinicalresultsoffirstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT liwenling s234updatedclinicalresultsoffirstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT zhangmingzhi s234updatedclinicalresultsoffirstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT zhangyi s234updatedclinicalresultsoffirstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma |